Prof. El Aidy wins Gut Microbiome Therapeutic Innovation challenge
Prof. Sahar El Aidy from the Groningen Biomolecular Sciences and Biotechnology Institute ( GBB ) has won the ProDigest and CosmosID Gut Microbiome Therapeutic Innovation ( GMTI ) challenge out of almost fifty submissions from all over the world. Prof. El Aidy won the challenge with her research plan to investigate the ‘Role of anti-Parkinson’s Disease (PD) medication in enhancing bacterial overgrowth and community dynamics along the gastrointestinal tract’. She receives EUR 50,000 to conduct her project on ProDigest’s gastrointestinal SHIME® platform, an in vitro simulator of the gastrointestinal tract.
The aim of the project is to identify which gut bacterial metabolites can improve or impair communication with the host gut-brain axis and effectiveness of drug treatments. According to the reviewing committee, the project of Prof. El Aidy ‘addresses the growing question of the role of the microbiota in the Parkinson’s Disease and of drug-bugs interactions’.
Last modified: | 27 June 2024 09.39 a.m. |
More news
-
29 April 2025
Impact | Rubber recycling
In the coming weeks the nominees for the Ben Feringa Impact Award 2025 will introduce themselves and their impactful research or project. This week: Francesco Picchioni on his innovative way to recycle rubber.
-
29 April 2025
Impact | Improving Human-AI Decision-Making in healthcare
In the coming weeks the nominees for the Ben Feringa Impact Award 2025 will introduce themselves and their impactful research or project. This week: Andra Cristiana Minculescu on her research project on Human-AI Decision-Making in healthcare.
-
28 April 2025
Engineering Smart Decisions for a Dynamic World
Dynamical systems, i.e. mathematical models that describe how things evolve over time, are at the heart of much of the modern world. The real challenge, however, lies in shaping the systems’ behaviour to achieve a specific goal.